title: Step-by-Step Technique for Irreversible Electroporation of Focal Prostate Cancer: An Instructional Video Guide.
abstract: Focal therapy has emerged as a tissue-sparing treatment modality for selected men with low to intermediate volume, localized prostate cancer with the advantage of reducing treatment morbidity because of preservation of untreated prostate tissue and surrounding structures. Irreversible electroporation is an emerging interventional focal therapy modality that uses high voltage electrical fields to induce cell death. This instructional video guide (Fig) serves as an easy-to-understand, comprehensive educational tool so that a broader audience can gain an understanding of the techniques involved in this treatment modality.
authors.affiliation: St Vincent's Prostate Cancer Centre, Level 6, 370 Victoria Street, Darlinghurst, NSW 2010, Australia; Garvan Institute of Medical Research and Kinghorn Cancer Centre, , Level 6, 370 Victoria Street, Darlinghurst, NSW 2010, Australia. Electronic address: francisting@gmail.com.
authors.forename: Francis
authors.initials: F
authors.lastname: Ting
authors.affiliation: St Vincent's Prostate Cancer Centre, Level 6, 370 Victoria Street, Darlinghurst, NSW 2010, Australia; Garvan Institute of Medical Research and Kinghorn Cancer Centre, , Level 6, 370 Victoria Street, Darlinghurst, NSW 2010, Australia.
authors.forename: Pim J
authors.initials: PJ
authors.lastname: Van Leeuwen
authors.affiliation: St Vincent's Prostate Cancer Centre, Level 6, 370 Victoria Street, Darlinghurst, NSW 2010, Australia; Garvan Institute of Medical Research and Kinghorn Cancer Centre, , Level 6, 370 Victoria Street, Darlinghurst, NSW 2010, Australia.
authors.forename: Phillip D
authors.initials: PD
authors.lastname: Stricker
mesh_terms: D055011:Ablation Techniques / Q000009:adverse effects / Q000379:methods*; D018274:Electroporation; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D011471:Prostatic Neoplasms / Q000473:pathology / Q000601:surgery*; D014022:Tissue Survival; D016896:Treatment Outcome; D047368:Tumor Burden